Titan Pharmaceuticals
TTNP
$6.97
Share price
-3.33%
Change (1 day)
817.11%
Change (1 year)
Categories
Market capitalization of Titan Pharmaceuticals (TTNP)
Market cap: $6.37 Million
As of April 2024 Titan Pharmaceuticals has a market cap of $6.37 Million. This makes Titan Pharmaceuticals the world's 8203th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Titan Pharmaceuticals from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $6.37 M | 2.53% |
| 2023 | $6.21 M | -45.75% |
| 2022 | $11.45 M | 13.29% |
| 2021 | $10.11 M | -53.78% |
| 2020 | $21.87 M | 96.44% |
| 2019 | $11.13 M | -36.02% |
| 2018 | $17.4 M | -38.04% |
| 2017 | $28.09 M | -66.87% |
| 2016 | $84.79 M | -4.79% |
| 2015 | $89.06 M | 75.26% |
| 2014 | $50.81 M | -5.4% |
| 2013 | $53.72 M | -35.07% |
| 2012 | $82.73 M | 22.21% |
| 2011 | $67.69 M | -3.98% |
| 2010 | $70.5 M | -47.64% |
| 2009 | $0.13 B | 10400.01% |
| 2008 | $1.28 M | -98.3% |
| 2007 | $75.56 M | -41.5% |
| 2006 | $0.12 B | 177.67% |
| 2005 | $46.52 M | -55.27% |
| 2004 | $0.10 B | 23.36% |
| 2003 | $84.31 M | 113.3% |
| 2002 | $39.52 M | -85.43% |
| 2001 | $0.27 B |
End of Day market cap according to different sources
On Apr 23rd, 2024 the market cap of Titan Pharmaceuticals was reported to be:
$6.4 Million
$6.4 Million
$6.4 Million
$6.44 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $357.92 B | 5,616,860.92% | 🇺🇸 USA |
 Novartis NVS | $201.13 B | 3,156,379.81% | 🇨🇭 Switzerland |
 Vanda Pharmaceuticals VNDA | $0.26 B | 4,017.42% | 🇺🇸 USA |
 Repligen
RGEN | $9.37 B | 146,992.60% | 🇺🇸 USA |
 MediciNova MNOV | $66.45 M | 942.93% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $2.43 B | 38,068.32% | 🇺🇸 USA |